Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ARISAN THERAPEUTICS INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-09-28 to 2024-09-27
Current total value of award: $526793.52
Description: PHASE II BASE PERIOD